Literature DB >> 32253639

Validation of two US breast cancer risk prediction models in German women.

Anika Hüsing1, Anne S Quante2, Jenny Chang-Claude1,3, Krasimira Aleksandrova4, Rudolf Kaaks1, Ruth M Pfeiffer5.   

Abstract

PURPOSE: There are no models for German women that predict absolute risk of invasive breast cancer (BC), i.e., the probability of developing BC over a prespecified time period, given a woman's age and characteristics, while accounting for competing risks. We thus validated two absolute BC risk models (BCRAT, BCRmod) developed for US women in German women. BCRAT uses a woman's medical, reproductive, and BC family history; BCRmod adds modifiable risk factors (body mass index, hormone replacement therapy and alcohol use).
METHODS: We assessed model calibration by comparing observed BC numbers (O) to expected numbers (E) computed from BCRmod/BCRAT for German women enrolled in the prospective European Prospective Investigation into Cancer and Nutrition (EPIC), and after updating the models with German BC incidence/competing mortality rates. We also compared 1-year BC risk predicted for all German women using the German Health Interview and Examination Survey for Adults (DEGS) with overall German BC incidence. Discriminatory performance was quantified by the area under the receiver operator characteristics curve (AUC).
RESULTS: Among 22,098 EPIC-Germany women aged 40+ years, 745 BCs occurred (median follow-up: 11.9 years). Both models had good calibration for total follow-up, EBCRmod/O = 1.08 (95% confidence interval: 0.95-1.21), and EBCRAT/O = 0.99(0.87-1.11), and over 5 years. Compared to German BC incidence rates, both models somewhat overestimated 1-year risk for women aged 55+ and 70+ years. For total follow-up, AUCBCRmod = 0.61(0.58-0.63) and AUCBCRAT = 0.58(0.56-0.61), with similar values for 5-year follow-up.
CONCLUSION: US BC risk models showed adequate calibration in German women. Discriminatory performance was comparable to that in US women. These models thus could be applied for risk prediction in German women.

Entities:  

Keywords:  Absolute risk; Breast cancer incidence; Model transportability

Mesh:

Year:  2020        PMID: 32253639      PMCID: PMC8900529          DOI: 10.1007/s10552-020-01272-6

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  26 in total

1.  Proportion of U.S. Trends in Breast Cancer Incidence Attributable to Long-term Changes in Risk Factor Distributions.

Authors:  Ruth M Pfeiffer; Yenny Webb-Vargas; William Wheeler; Mitchell H Gail
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-08-01       Impact factor: 4.254

2.  Risk factor modification and projections of absolute breast cancer risk.

Authors:  Elisabetta Petracci; Adriano Decarli; Catherine Schairer; Ruth M Pfeiffer; David Pee; Giovanna Masala; Domenico Palli; Mitchell H Gail
Journal:  J Natl Cancer Inst       Date:  2011-06-24       Impact factor: 13.506

3.  Validation studies for models projecting the risk of invasive and total breast cancer incidence.

Authors:  J P Costantino; M H Gail; D Pee; S Anderson; C K Redmond; J Benichou; H S Wieand
Journal:  J Natl Cancer Inst       Date:  1999-09-15       Impact factor: 13.506

4.  Population attributable risk of invasive postmenopausal breast cancer and breast cancer subtypes for modifiable and non-modifiable risk factors.

Authors:  Benjamin B E Barnes; Karen Steindorf; Rebecca Hein; Dieter Flesch-Janys; Jenny Chang-Claude
Journal:  Cancer Epidemiol       Date:  2010-12-14       Impact factor: 2.984

5.  Projecting individualized absolute invasive breast cancer risk in African American women.

Authors:  Mitchell H Gail; Joseph P Costantino; David Pee; Melissa Bondy; Lisa Newman; Mano Selvan; Garnet L Anderson; Kathleen E Malone; Polly A Marchbanks; Worta McCaskill-Stevens; Sandra A Norman; Michael S Simon; Robert Spirtas; Giske Ursin; Leslie Bernstein
Journal:  J Natl Cancer Inst       Date:  2007-11-27       Impact factor: 13.506

Review 6.  Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018.

Authors:  J Ferlay; M Colombet; I Soerjomataram; T Dyba; G Randi; M Bettio; A Gavin; O Visser; F Bray
Journal:  Eur J Cancer       Date:  2018-08-09       Impact factor: 9.162

7.  Contribution of three components to individual cancer risk predicting breast cancer risk in Italy.

Authors:  P Boyle; M Mezzetti; C La Vecchia; S Franceschi; A Decarli; C Robertson
Journal:  Eur J Cancer Prev       Date:  2004-06       Impact factor: 2.497

8.  Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts.

Authors:  Kuanrong Li; Garnet Anderson; Vivian Viallon; Patrick Arveux; Marina Kvaskoff; Agnès Fournier; Vittorio Krogh; Rosario Tumino; Maria-Jose Sánchez; Eva Ardanaz; María-Dolores Chirlaque; Antonio Agudo; David C Muller; Todd Smith; Ioanna Tzoulaki; Timothy J Key; Bas Bueno-de-Mesquita; Antonia Trichopoulou; Christina Bamia; Philippos Orfanos; Rudolf Kaaks; Anika Hüsing; Renée T Fortner; Anne Zeleniuch-Jacquotte; Malin Sund; Christina C Dahm; Kim Overvad; Dagfinn Aune; Elisabete Weiderpass; Isabelle Romieu; Elio Riboli; Marc J Gunter; Laure Dossus; Ross Prentice; Pietro Ferrari
Journal:  Breast Cancer Res       Date:  2018-12-03       Impact factor: 6.466

9.  Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.

Authors:  Ruth M Pfeiffer; Yikyung Park; Aimée R Kreimer; James V Lacey; David Pee; Robert T Greenlee; Saundra S Buys; Albert Hollenbeck; Bernard Rosner; Mitchell H Gail; Patricia Hartge
Journal:  PLoS Med       Date:  2013-07-30       Impact factor: 11.069

10.  Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States.

Authors:  Paige Maas; Myrto Barrdahl; Amit D Joshi; Paul L Auer; Mia M Gaudet; Roger L Milne; Fredrick R Schumacher; William F Anderson; David Check; Subham Chattopadhyay; Laura Baglietto; Christine D Berg; Stephen J Chanock; David G Cox; Jonine D Figueroa; Mitchell H Gail; Barry I Graubard; Christopher A Haiman; Susan E Hankinson; Robert N Hoover; Claudine Isaacs; Laurence N Kolonel; Loic Le Marchand; I-Min Lee; Sara Lindström; Kim Overvad; Isabelle Romieu; Maria-Jose Sanchez; Melissa C Southey; Daniel O Stram; Rosario Tumino; Tyler J VanderWeele; Walter C Willett; Shumin Zhang; Julie E Buring; Federico Canzian; Susan M Gapstur; Brian E Henderson; David J Hunter; Graham G Giles; Ross L Prentice; Regina G Ziegler; Peter Kraft; Montse Garcia-Closas; Nilanjan Chatterjee
Journal:  JAMA Oncol       Date:  2016-10-01       Impact factor: 31.777

View more
  1 in total

1.  Estimating the Breast Cancer Burden in Germany and Implications for Risk-based Screening.

Authors:  Anne S Quante; Anika Hüsing; Jenny Chang-Claude; Marion Kiechle; Rudolf Kaaks; Ruth M Pfeiffer
Journal:  Cancer Prev Res (Phila)       Date:  2021-03-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.